Are Gadolinium-based Contrast Media Really Safer than Iodinated Media for Digital Subtraction Angiography in Patients with Azotemia?

  • Nyman U
  • Elmstahl B
  • Leander P
 et al. 
  • 8

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

Gadolinium chelates, intended as intravenous contrast media for magnetic resonance imaging, have been regarded as nonnephrotoxic and recommended to replace iodinated contrast media in patients with azotemia who are undergoing digital subtraction angiography (DSA). High intraarterial doses (up to 220 mmol of gadodiamide) have been used, with a 40% incidence of nephropathy. The authors discourage the use of gadolinium for DSA for several reasons. (a) There exist no randomized studies comparing the nephrotoxic effects of gadolinium-based and iodinated media at equal-attenuating concentrations and doses. (b) Gadolinium-based media are hypertonic, a pathogenetic factor in contrast medium-induced nephropathy after renal angiography, with an osmolality two to seven times that of plasma. Iodinated media in concentrations that are equally attenuating with gadolinium-based media can be made isotonic. (c) In vitro measurements indicate that 0.5 mol/L gadolinium chelates are equally attenuating with 60-80 mg iodine per milliliter at the commonly used 70-90-kV range used for DSA. Thus, 50 mL of 0.5 mol/L gadolinium chelate ( approximately 0.3 mmol/kg in an 80-kg person) would be equally attenuating with a dose of 3-4 g of iodine in an iodinated medium (eg, 50 mL iohexol at 60-80 mg I/mL or 10-13 mL at 300 mg I/mL). (d) By combining these data on attenuation and results of toxicity studies in mice, the general toxicity of gadolinium chelates may be six to 25 times higher than that of equal-attenuating doses of iodinated media at 70-kV DSA. Thus, the authors believe that at equal-attenuating doses for DSA, modern iodinated contrast media should result in a lower toxic load on the body than with presently available gadolinium chelates.

Author-supplied keywords

  • Angiography, Digital Subtraction
  • Chelating Agents
  • Chelating Agents: adverse effects
  • Chelating Agents: chemistry
  • Chelating Agents: diagnostic use
  • Contrast Media
  • Contrast Media: adverse effects
  • Contrast Media: chemistry
  • Gadolinium DTPA
  • Gadolinium DTPA: adverse effects
  • Gadolinium DTPA: chemistry
  • Gadolinium DTPA: diagnostic use
  • Humans
  • Kidney Diseases
  • Kidney Diseases: chemically induced
  • Radiology, Interventional
  • Triiodobenzoic Acids
  • Triiodobenzoic Acids: adverse effects
  • Triiodobenzoic Acids: chemistry
  • Triiodobenzoic Acids: diagnostic use
  • Uremia
  • Uremia: complications

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Authors

  • U. Nyman

  • B. Elmstahl

  • P. Leander

  • M. Nilsson

  • K. Golman

  • T. Almen

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free